Rheumatology Thrombotic Risk in Rheumatoid Arthritis: Is It Increased by Janus Kinase Inhibitors? clinical topic updates By Jonathan Kay, MD
Oncology Precision Medicine in Patients With Non–Small Cell Lung Cancer and Rare Mutations expert roundtables By Bruce E. Johnson, MD; Gregory J. Riely, MD, PhD; Roy S. Herbst, MD, PhD
Oncology Immunotherapy and Targeted Therapies in Non–Small Cell Lung Cancer expert roundtables By Bruce E. Johnson, MD; Gregory J. Riely, MD, PhD; Roy S. Herbst, MD, PhD
Oncology Recommended Predictive Molecular Testing for Non–Small Cell Lung Cancer patient care perspectives By Bruce E. Johnson, MD
Oncology Managing Side Effects of Precision Lung Cancer Therapies patient care perspectives By Roy S. Herbst, MD, PhD